A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

Paclitaxel and capecitabine, which have distinct mechanisms of action and toxicity profiles, have each shown high activity as single agents in gastric cancer. Synergistic interaction between these two drugs was suggested by taxane-induced upregulation of thymidine phosphorylase. We, therefore, evalu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kang, H J, Chang, H M, Kim, T W, Ryu, M-H, Sohn, H-J, Yook, J H, Oh, S T, Kim, B S, Lee, J-S, Kang, Y-K
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361449/
https://ncbi.nlm.nih.gov/pubmed/18219288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604186
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares